Come and join us across the globe
Sign In

HEMERA 1 CarboxyHEMoglobin OxygEn delivery for Revascularization in Acute Stroke: Randomized Phase 1 Clinical Trial

Last update on June 7, 2023

Watch Italo Linfante explore the results of HEMERA 1 - The purpose of the study was to assess the potential benefits of using carboxyhaemoglobin to enhance oxygen delivery to affected brain regions during acute stroke, with the primary aim of refining revascularization techniques and improving patient outcomes. Find out more about the study's findings and grasp the potential implications for your clinical practice.

Sign to LINNC online

Lost Password?
Not registered? Create free account
On the same subject
Come and join us across the globe